Barclays’s Aphria Inc. Common Shares APHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,356
Closed -$26K 5197
2021
Q1
$26K Sell
1,356
-45,965
-97% -$745K ﹤0.01% 4329
2020
Q4
$327K Buy
47,321
+31,767
+204% +$198K ﹤0.01% 3504
2020
Q3
$69K Buy
15,554
+3,378
+28% +$15.8K ﹤0.01% 4443
2020
Q2
$52K Buy
12,176
+8,999
+283% +$34.5K ﹤0.01% 4919
2020
Q1
$10K Hold
3,177
﹤0.01% 5829
2019
Q4
$17K Sell
3,177
-44,500
-93% -$219K ﹤0.01% 6019
2019
Q3
$248K Buy
47,677
+605
+1% +$3.84K ﹤0.01% 4813
2019
Q2
$331K Buy
47,072
+43,895
+1,382% +$332K ﹤0.01% 4688
2019
Q1
$30K Sell
3,177
-100,000
-97% -$878K ﹤0.01% 6180
2018
Q4
$587K Buy
+103,177
New +$813K ﹤0.01% 3664

Barclays's APHA Position: Q2 2021 in Review

Barclays sold out of Aphria Inc. Common Shares (APHA) in Q2 2021, closing a stake of 1,356 shares — an estimated $26K sold.

Barclays first reported a position in APHA in Q4 2018 and held it in 10 quarters. The position peaked at $587K in Q4 2018. 0 funds tracked by Wall St. Rank hold APHA as of Q2 2021.

  • Barclays reported no remaining Aphria Inc. Common Shares position as of Q2 2021 after selling out during the quarter.
  • Barclays sold 1,356 Aphria Inc. Common Shares shares in Q2 2021, an estimated $26K.
  • Barclays first reported a position in Aphria Inc. Common Shares in Q4 2018 and held it in 10 quarters.
  • Barclays's Aphria Inc. Common Shares position peaked at $587K in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Aphria Inc. Common Shares as of Q2 2021.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.